New Generation Nuclear Radioisotope Reactor Infrastructure to Power the Future of Cancer Diagnosis and Treatment
Investors have a rare chance to lead and shape the only purpose-
built, low-cost, North-American isotope platform just as demand
explodes and legacy reactors retire.
Acting now secures a preferred position for follow-on rounds,
aligns capital with life-saving impact, and targets venture-style
multiples backed by long-term infrastructure economics.